Pou6f1 transcriptional control of memory CD8+ T cells
Pou6f1 记忆 CD8 T 细胞的转录控制
基本信息
- 批准号:8264746
- 负责人:
- 金额:$ 20.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-06-01 至 2013-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesAutoimmune DiseasesAutomobile DrivingB-LymphocytesBacterial InfectionsBiochemicalCD8-Positive T-LymphocytesCD8B1 geneCancer VaccinesCellsEffector CellExhibitsFamilyGenerationsGenesGeneticGenetic ProgrammingGenetic TranscriptionHematopoietic stem cellsImmuneImmune responseImmunityInfectionInterleukin-15Interleukin-7LeadLifeListeria monocytogenesLymphocyteMaintenanceMature LymphocyteMemoryMemory B-LymphocyteMusPopulationProliferatingProto-Oncogene Proteins c-aktPublishingRelative (related person)Reserve Stem CellRoleSeriesSignal PathwaySignal TransductionStem cellsT memory cellT-LymphocyteTamoxifenTestingTherapeuticTranscriptional RegulationVaccinesVaccinia virusVirus Diseasesdesignembryonic stem cellgranzyme Bhuman FRAP1 proteinin vivoinsightmemberparalogous genepathogenpromoterpublic health relevancerecombinaseresearch studyresponseself-renewaltranscription factor
项目摘要
DESCRIPTION (provided by applicant): In order to protect us from pathogen reexposure, memory lymphocytes must undergo homeostatic self-renewal and remain poised to respond to subsequent infection. In the case of CD8+ T cells, several antagonistic pairs of transcription factors appear to regulate the initial decision to become a terminally differentiated effector cell or a self- renewing memory cell. However, it remains unclear how these transcription factors are themselves coordinately regulated, and further which genetic circuits are responsible for subsequent memory cell self-renewal. Given that memory lymphocytes exhibit many of the functional attributes typically associated with stem cells, we hypothesized that memory lymphocytes have reactivated a portion of the hematopoietic stem cell genetic program. In support of this idea, we published a common transcriptional signature shared between memory B cells, memory CD8+ T cells and hematopoietic stem cells. We further identified a transcription factor, Pou6f1, that is selectively upregulated in memory B and CD8+ T cells relative to shorter-lived cells. Pou6f1 is a member of the Pou-domain family of transcription factors and is a paralog of the embryonic stem cell self-renewal regulator Pou5f1 (aka Oct4). We believe Pou6f1 functions in memory CD8+ T cells in a manner similar to Oct4 in embryonic stem cells. The central hypothesis of this proposal is that Pou6f1 directs memory CD8+ T cell self-renewal by establishing and maintaining a self-reinforcing genetic circuit that coordinates the expression of multiple transcription factors and signaling pathways. In order to test this hypothesis in vivo, we have generated mice expressing two different floxed alleles of Pou6f1 that will allow us to test Pou6f1's functional relevance and identify Pou6f1's transcriptional targets in memory CD8+ T cells. By elucidating the core genetic circuitry responsible for memory CD8+ T cell generation, function and maintenance, this proposal will provide key insights into the mechanisms controlling adaptive immune memory.
PUBLIC HEALTH RELEVANCE: Memory lymphocytes are responsible for long-lived immunity, driving immune responses that can be either life-saving (as in the case of vaccines) or life-threatening (as in the case of autoimmune diseases). Despite the importance of memory cells, there are no memory-specific therapies currently available. In the fullness of time, we anticipate that identification of the genetic circuitry of CD8+ T cell memory, its targets, and the upstream signaling network that drives it will provide potential therapeutic candidates that might be used to aid in the design of more efficacious therapeutic cancer vaccines.
描述(由申请人提供):为了保护我们免受病原体的再次暴露,记忆淋巴细胞必须进行稳态自我更新,并保持对后续感染的反应。在CD8+ T细胞的情况下,几对拮抗性转录因子似乎调节成为终末分化效应细胞或自我更新记忆细胞的初始决定。然而,目前还不清楚这些转录因子本身是如何协调调节的,以及哪些遗传电路负责随后的记忆细胞自我更新。鉴于记忆淋巴细胞表现出许多通常与干细胞相关的功能属性,我们假设记忆淋巴细胞重新激活了造血干细胞遗传程序的一部分。为了支持这一观点,我们发表了记忆B细胞、记忆CD8+ T细胞和造血干细胞之间共享的共同转录特征。我们进一步确定了一个转录因子,Pou6f1,这是选择性上调记忆B和CD8+ T细胞相对于寿命较短的细胞。Pou6f1是转录因子Pou结构域家族的一员,是胚胎干细胞自我更新调节因子Pou5f1(又名Oct4)的一部分。我们相信Pou6f1在记忆性CD8+ T细胞中的功能与胚胎干细胞中的Oct4类似。该提议的中心假设是Pou6f1通过建立和维持协调多种转录因子和信号通路表达的自我增强遗传电路来指导记忆性CD8+ T细胞自我更新。为了在体内测试这一假设,我们已经产生了表达Pou6f1的两种不同的floxed等位基因的小鼠,这将使我们能够测试Pou6f1的功能相关性,并确定Pou6f1在记忆CD8+ T细胞中的转录靶点。通过阐明负责记忆CD8+ T细胞生成、功能和维持的核心遗传电路,该提案将为控制适应性免疫记忆的机制提供关键见解。
公共卫生相关性:记忆淋巴细胞负责长期免疫,驱动免疫反应,可以挽救生命(如疫苗)或威胁生命(如自身免疫性疾病)。尽管记忆细胞很重要,但目前还没有记忆特异性疗法。随着时间的推移,我们预计CD8+ T细胞记忆的遗传电路、其靶点以及驱动它的上游信号网络的鉴定将提供潜在的治疗候选物,这些候选物可用于帮助设计更有效的治疗性癌症疫苗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHANCE MARION JOHN LUCKEY其他文献
CHANCE MARION JOHN LUCKEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHANCE MARION JOHN LUCKEY', 18)}}的其他基金
Basic and Translational Mechanisms of Alloimmunization to RBC Transfusion. Project 2
红细胞输注同种免疫的基本和转化机制。
- 批准号:
10711669 - 财政年份:2023
- 资助金额:
$ 20.79万 - 项目类别:
Molecular determinants of anti-RBC alloantibody evanescence
抗红细胞同种抗体消失的分子决定因素
- 批准号:
10687424 - 财政年份:2022
- 资助金额:
$ 20.79万 - 项目类别:
Cellular and Molecular Determinants of RBC Alloimmunization Responder Status
红细胞同种免疫应答状态的细胞和分子决定因素
- 批准号:
10192795 - 财政年份:2017
- 资助金额:
$ 20.79万 - 项目类别:
Cyokine control of red blood cell alloimmunization
红细胞同种免疫的细胞因子控制
- 批准号:
9214994 - 财政年份:2016
- 资助金额:
$ 20.79万 - 项目类别:
Transcriptional Control of Memory Responses to Red Blood Cell Alloimmunization
红细胞同种免疫记忆反应的转录控制
- 批准号:
9017157 - 财政年份:2014
- 资助金额:
$ 20.79万 - 项目类别:
Transcriptional Control of Memory Responses to Red Blood Cell Alloimmunization
红细胞同种免疫记忆反应的转录控制
- 批准号:
8567036 - 财政年份:2013
- 资助金额:
$ 20.79万 - 项目类别:
Transcriptional Control of Memory Responses to Red Blood Cell Alloimmunization
红细胞同种免疫记忆反应的转录控制
- 批准号:
8703785 - 财政年份:2013
- 资助金额:
$ 20.79万 - 项目类别:
Cytokine control of Red Blood Cell Alloimmunization
红细胞同种免疫的细胞因子控制
- 批准号:
8228956 - 财政年份:2012
- 资助金额:
$ 20.79万 - 项目类别:
Cytokine control of Red Blood Cell Alloimmunization
红细胞同种免疫的细胞因子控制
- 批准号:
8424288 - 财政年份:2012
- 资助金额:
$ 20.79万 - 项目类别:
Pou6f1 transcriptional control of memory CD8+ T cells
Pou6f1 记忆 CD8 T 细胞的转录控制
- 批准号:
8164939 - 财政年份:2011
- 资助金额:
$ 20.79万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 20.79万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 20.79万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 20.79万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 20.79万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 20.79万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 20.79万 - 项目类别:
Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 20.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 20.79万 - 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 20.79万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 20.79万 - 项目类别: